Gene Symbol | Gene ID | Gene Info |
---|---|---|
FLI1
|
ENSG00000151702.12 | Fli-1 proto-oncogene, ETS transcription factor |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr11_128660057_128660214 | FLI1 | 25450 | 0.181398 | -0.81 | 7.9e-03 | Click! |
chr11_128636422_128636573 | FLI1 | 1812 | 0.401136 | -0.80 | 9.7e-03 | Click! |
chr11_128646889_128647040 | FLI1 | 12279 | 0.216354 | -0.72 | 2.7e-02 | Click! |
chr11_128559988_128560195 | FLI1 | 2298 | 0.263741 | -0.68 | 4.3e-02 | Click! |
chr11_128560277_128560436 | FLI1 | 2033 | 0.289453 | -0.64 | 6.1e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr1_161038546_161039545 | 1.04 |
ARHGAP30 |
Rho GTPase activating protein 30 |
411 |
0.65 |
chr2_61095077_61095367 | 0.85 |
REL |
v-rel avian reticuloendotheliosis viral oncogene homolog |
13434 |
0.18 |
chr3_177256670_177257021 | 0.80 |
ENSG00000252028 |
. |
35505 |
0.22 |
chr22_33040519_33040909 | 0.77 |
ENSG00000251890 |
. |
9530 |
0.25 |
chr18_13464907_13465379 | 0.77 |
LDLRAD4 |
low density lipoprotein receptor class A domain containing 4 |
129 |
0.93 |
chr11_6767215_6767876 | 0.76 |
OR2AG2 |
olfactory receptor, family 2, subfamily AG, member 2 |
22741 |
0.11 |
chr14_88471433_88472132 | 0.73 |
GPR65 |
G protein-coupled receptor 65 |
314 |
0.88 |
chr17_4389769_4390006 | 0.70 |
RP13-580F15.2 |
|
239 |
0.89 |
chr17_7239932_7240900 | 0.69 |
ACAP1 |
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
507 |
0.51 |
chr2_231508439_231508868 | 0.69 |
ENSG00000199791 |
. |
56817 |
0.11 |
chr1_150082423_150082787 | 0.68 |
PLEKHO1 |
pleckstrin homology domain containing, family O member 1 |
38768 |
0.11 |
chr12_58135257_58135844 | 0.67 |
AGAP2 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
390 |
0.63 |
chr12_9912315_9912520 | 0.66 |
CD69 |
CD69 molecule |
1080 |
0.47 |
chr10_43947307_43947516 | 0.66 |
ENSG00000252532 |
. |
6102 |
0.17 |
chr2_242556723_242557374 | 0.64 |
THAP4 |
THAP domain containing 4 |
132 |
0.94 |
chr6_35279100_35279566 | 0.64 |
DEF6 |
differentially expressed in FDCP 6 homolog (mouse) |
1818 |
0.34 |
chr2_182324285_182324673 | 0.64 |
ITGA4 |
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) |
2324 |
0.44 |
chr13_75900993_75901212 | 0.63 |
TBC1D4 |
TBC1 domain family, member 4 |
14565 |
0.24 |
chr3_3214996_3215328 | 0.63 |
CRBN |
cereblon |
6196 |
0.2 |
chr1_64709067_64709297 | 0.62 |
UBE2U |
ubiquitin-conjugating enzyme E2U (putative) |
22635 |
0.23 |
chr5_130882612_130883040 | 0.62 |
RAPGEF6 |
Rap guanine nucleotide exchange factor (GEF) 6 |
14100 |
0.29 |
chr17_75662930_75663081 | 0.61 |
SEPT9 |
septin 9 |
185010 |
0.03 |
chr19_3179462_3180177 | 0.60 |
S1PR4 |
sphingosine-1-phosphate receptor 4 |
1083 |
0.38 |
chr14_105527834_105528220 | 0.60 |
GPR132 |
G protein-coupled receptor 132 |
3740 |
0.23 |
chr10_134260489_134261029 | 0.60 |
C10orf91 |
chromosome 10 open reading frame 91 |
2066 |
0.3 |
chr10_28622520_28622887 | 0.60 |
MPP7 |
membrane protein, palmitoylated 7 (MAGUK p55 subfamily member 7) |
712 |
0.72 |
chr2_68592484_68592752 | 0.56 |
AC015969.3 |
|
98 |
0.77 |
chr20_58630648_58631293 | 0.56 |
C20orf197 |
chromosome 20 open reading frame 197 |
10 |
0.98 |
chr11_67176589_67176876 | 0.55 |
TBC1D10C |
TBC1 domain family, member 10C |
5072 |
0.07 |
chr1_239883177_239883989 | 0.55 |
CHRM3 |
cholinergic receptor, muscarinic 3 |
740 |
0.59 |
chr15_75160410_75160789 | 0.55 |
SCAMP2 |
secretory carrier membrane protein 2 |
4782 |
0.12 |
chr12_53024457_53024608 | 0.55 |
KRT73 |
keratin 73 |
12189 |
0.1 |
chr10_94590680_94591107 | 0.54 |
EXOC6 |
exocyst complex component 6 |
42 |
0.99 |
chr14_100532787_100533367 | 0.54 |
EVL |
Enah/Vasp-like |
303 |
0.88 |
chr4_40199803_40200006 | 0.54 |
RHOH |
ras homolog family member H |
1377 |
0.47 |
chr11_64509794_64509966 | 0.54 |
RASGRP2 |
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
529 |
0.68 |
chr3_121379230_121379471 | 0.53 |
HCLS1 |
hematopoietic cell-specific Lyn substrate 1 |
395 |
0.81 |
chr16_80598262_80598561 | 0.53 |
RP11-525K10.3 |
|
1379 |
0.4 |
chr1_209929583_209930044 | 0.53 |
TRAF3IP3 |
TRAF3 interacting protein 3 |
289 |
0.87 |
chr2_98334930_98335281 | 0.52 |
ZAP70 |
zeta-chain (TCR) associated protein kinase 70kDa |
5082 |
0.19 |
chr2_191929470_191929872 | 0.52 |
ENSG00000231858 |
. |
43419 |
0.12 |
chr10_111817998_111818272 | 0.52 |
ADD3 |
adducin 3 (gamma) |
50413 |
0.13 |
chr19_3136242_3137376 | 0.51 |
GNA15 |
guanine nucleotide binding protein (G protein), alpha 15 (Gq class) |
618 |
0.58 |
chr5_61874491_61874642 | 0.50 |
LRRC70 |
leucine rich repeat containing 70 |
4 |
0.56 |
chr19_6481304_6482171 | 0.50 |
DENND1C |
DENN/MADD domain containing 1C |
27 |
0.95 |
chr1_198609761_198609912 | 0.49 |
PTPRC |
protein tyrosine phosphatase, receptor type, C |
1544 |
0.48 |
chr1_198504017_198504170 | 0.49 |
ATP6V1G3 |
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3 |
5711 |
0.32 |
chr20_35258352_35258894 | 0.49 |
SLA2 |
Src-like-adaptor 2 |
15661 |
0.12 |
chr7_150329208_150329551 | 0.49 |
GIMAP6 |
GTPase, IMAP family member 6 |
55 |
0.98 |
chr2_113933295_113933446 | 0.49 |
AC016683.5 |
|
433 |
0.74 |
chr1_25254983_25255134 | 0.49 |
RUNX3 |
runt-related transcription factor 3 |
554 |
0.81 |
chr4_40208145_40208346 | 0.49 |
RHOH |
ras homolog family member H |
6281 |
0.23 |
chr11_10645165_10645316 | 0.49 |
MRVI1 |
murine retrovirus integration site 1 homolog |
28492 |
0.14 |
chr9_134150453_134150757 | 0.49 |
FAM78A |
family with sequence similarity 78, member A |
1329 |
0.42 |
chr7_150148744_150149359 | 0.49 |
GIMAP8 |
GTPase, IMAP family member 8 |
1333 |
0.41 |
chr1_160676943_160677601 | 0.48 |
CD48 |
CD48 molecule |
4321 |
0.18 |
chr7_45017629_45017804 | 0.48 |
MYO1G |
myosin IG |
981 |
0.45 |
chr7_38398847_38399253 | 0.47 |
AMPH |
amphiphysin |
103663 |
0.08 |
chr7_137619960_137620169 | 0.47 |
CREB3L2 |
cAMP responsive element binding protein 3-like 2 |
1428 |
0.46 |
chr22_40298890_40299260 | 0.47 |
GRAP2 |
GRB2-related adaptor protein 2 |
1962 |
0.3 |
chr2_158296564_158297076 | 0.46 |
CYTIP |
cytohesin 1 interacting protein |
894 |
0.5 |
chr1_12405311_12405726 | 0.46 |
VPS13D |
vacuolar protein sorting 13 homolog D (S. cerevisiae) |
64406 |
0.11 |
chr1_6086479_6086932 | 0.45 |
KCNAB2 |
potassium voltage-gated channel, shaker-related subfamily, beta member 2 |
325 |
0.88 |
chr2_175498105_175498391 | 0.45 |
WIPF1 |
WAS/WASL interacting protein family, member 1 |
1059 |
0.58 |
chr1_117297598_117297897 | 0.45 |
CD2 |
CD2 molecule |
658 |
0.75 |
chr17_265803_266293 | 0.45 |
AC108004.3 |
|
2234 |
0.23 |
chr17_4336857_4337447 | 0.45 |
SPNS3 |
spinster homolog 3 (Drosophila) |
67 |
0.97 |
chr12_96605794_96606075 | 0.45 |
RP11-394J1.2 |
|
11817 |
0.2 |
chr5_156608214_156608444 | 0.45 |
ITK |
IL2-inducible T-cell kinase |
492 |
0.72 |
chr11_1874347_1875032 | 0.44 |
LSP1 |
lymphocyte-specific protein 1 |
489 |
0.65 |
chr5_130617597_130618118 | 0.44 |
CDC42SE2 |
CDC42 small effector 2 |
18064 |
0.27 |
chr19_15574418_15574723 | 0.44 |
RASAL3 |
RAS protein activator like 3 |
812 |
0.5 |
chrX_78417700_78417909 | 0.44 |
GPR174 |
G protein-coupled receptor 174 |
8665 |
0.33 |
chr13_114905676_114905991 | 0.44 |
RASA3 |
RAS p21 protein activator 3 |
7747 |
0.23 |
chr14_22538566_22539116 | 0.44 |
ENSG00000238634 |
. |
72046 |
0.12 |
chrX_4158791_4158942 | 0.44 |
ENSG00000264861 |
. |
342675 |
0.01 |
chr3_56789114_56789483 | 0.44 |
ARHGEF3 |
Rho guanine nucleotide exchange factor (GEF) 3 |
20297 |
0.25 |
chr3_111261912_111262220 | 0.44 |
CD96 |
CD96 molecule |
1069 |
0.62 |
chr3_112215334_112215665 | 0.44 |
BTLA |
B and T lymphocyte associated |
2706 |
0.33 |
chr1_111416320_111416529 | 0.43 |
CD53 |
CD53 molecule |
648 |
0.73 |
chr19_10449910_10450285 | 0.43 |
ICAM3 |
intercellular adhesion molecule 3 |
198 |
0.86 |
chr12_10220623_10220774 | 0.43 |
ENSG00000223042 |
. |
16087 |
0.12 |
chr19_6773526_6773780 | 0.43 |
VAV1 |
vav 1 guanine nucleotide exchange factor |
684 |
0.58 |
chr12_117535875_117536067 | 0.43 |
TESC |
tescalcin |
1280 |
0.57 |
chr20_25017046_25017337 | 0.43 |
ACSS1 |
acyl-CoA synthetase short-chain family member 1 |
3852 |
0.24 |
chr9_130665887_130666038 | 0.43 |
ST6GALNAC6 |
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 |
1647 |
0.19 |
chr22_17700031_17700512 | 0.43 |
CECR1 |
cat eye syndrome chromosome region, candidate 1 |
5 |
0.98 |
chr6_225379_225671 | 0.43 |
DUSP22 |
dual specificity phosphatase 22 |
66105 |
0.15 |
chr5_74964815_74965486 | 0.42 |
ENSG00000207333 |
. |
40274 |
0.14 |
chr16_50780900_50781420 | 0.42 |
CYLD |
cylindromatosis (turban tumor syndrome) |
2300 |
0.18 |
chr11_63974616_63975431 | 0.42 |
FERMT3 |
fermitin family member 3 |
266 |
0.78 |
chr14_24906611_24906867 | 0.42 |
SDR39U1 |
short chain dehydrogenase/reductase family 39U, member 1 |
3518 |
0.13 |
chr14_22952184_22952433 | 0.42 |
ENSG00000251002 |
. |
360 |
0.73 |
chr12_104871725_104872091 | 0.42 |
CHST11 |
carbohydrate (chondroitin 4) sulfotransferase 11 |
21129 |
0.25 |
chr5_171610848_171611129 | 0.42 |
STK10 |
serine/threonine kinase 10 |
4402 |
0.22 |
chr12_47609896_47610314 | 0.41 |
PCED1B |
PC-esterase domain containing 1B |
53 |
0.98 |
chr6_170404507_170404739 | 0.41 |
RP11-302L19.1 |
|
73118 |
0.11 |
chr11_68099084_68099235 | 0.41 |
LRP5 |
low density lipoprotein receptor-related protein 5 |
19082 |
0.2 |
chr4_84035760_84036001 | 0.41 |
PLAC8 |
placenta-specific 8 |
9 |
0.98 |
chr9_95726568_95726886 | 0.41 |
FGD3 |
FYVE, RhoGEF and PH domain containing 3 |
484 |
0.84 |
chr15_75069590_75069869 | 0.41 |
CSK |
c-src tyrosine kinase |
4669 |
0.13 |
chr1_204482334_204482501 | 0.41 |
MDM4 |
Mdm4 p53 binding protein homolog (mouse) |
3094 |
0.23 |
chr1_234980313_234980644 | 0.41 |
ENSG00000201638 |
. |
6758 |
0.28 |
chr1_27757398_27757629 | 0.41 |
GPR3 |
G protein-coupled receptor 3 |
38365 |
0.1 |
chr7_37486894_37487045 | 0.41 |
ELMO1 |
engulfment and cell motility 1 |
1584 |
0.4 |
chr17_81026922_81027073 | 0.40 |
METRNL |
meteorin, glial cell differentiation regulator-like |
10570 |
0.21 |
chr12_47609308_47609580 | 0.40 |
PCED1B |
PC-esterase domain containing 1B |
608 |
0.77 |
chr6_36975031_36975182 | 0.40 |
FGD2 |
FYVE, RhoGEF and PH domain containing 2 |
1683 |
0.34 |
chr1_26646074_26646278 | 0.40 |
UBXN11 |
UBX domain protein 11 |
1322 |
0.27 |
chr3_183273606_183273960 | 0.40 |
KLHL6 |
kelch-like family member 6 |
306 |
0.89 |
chr13_30947629_30947892 | 0.40 |
KATNAL1 |
katanin p60 subunit A-like 1 |
66139 |
0.12 |
chr2_97627619_97627770 | 0.40 |
ENSG00000252845 |
. |
5142 |
0.16 |
chr1_9777067_9777879 | 0.40 |
PIK3CD |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
654 |
0.69 |
chr12_7062613_7062865 | 0.40 |
PTPN6 |
protein tyrosine phosphatase, non-receptor type 6 |
2201 |
0.1 |
chr7_150382525_150383418 | 0.40 |
GIMAP2 |
GTPase, IMAP family member 2 |
156 |
0.95 |
chr1_206732541_206732911 | 0.40 |
RASSF5 |
Ras association (RalGDS/AF-6) domain family member 5 |
2233 |
0.27 |
chr9_92034055_92034354 | 0.40 |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
456 |
0.87 |
chr8_141608249_141608648 | 0.40 |
AGO2 |
argonaute RISC catalytic component 2 |
7539 |
0.25 |
chr2_8628153_8628374 | 0.39 |
AC011747.7 |
|
187633 |
0.03 |
chr19_48774376_48774742 | 0.39 |
ZNF114 |
zinc finger protein 114 |
70 |
0.95 |
chr14_91882732_91883366 | 0.39 |
CCDC88C |
coiled-coil domain containing 88C |
641 |
0.78 |
chr16_50308842_50309053 | 0.39 |
ADCY7 |
adenylate cyclase 7 |
883 |
0.62 |
chr7_38389675_38390189 | 0.39 |
AMPH |
amphiphysin |
112781 |
0.07 |
chr22_30698293_30698529 | 0.39 |
RP1-130H16.18 |
Uncharacterized protein |
2940 |
0.13 |
chrX_12969173_12969416 | 0.39 |
TMSB4X |
thymosin beta 4, X-linked |
23933 |
0.18 |
chr11_64107746_64107914 | 0.39 |
CCDC88B |
coiled-coil domain containing 88B |
135 |
0.9 |
chr1_112016807_112017159 | 0.39 |
C1orf162 |
chromosome 1 open reading frame 162 |
492 |
0.65 |
chr16_67679075_67679512 | 0.39 |
RLTPR |
RGD motif, leucine rich repeats, tropomodulin domain and proline-rich containing |
143 |
0.91 |
chrX_56791675_56792116 | 0.39 |
ENSG00000204272 |
. |
36203 |
0.23 |
chr11_122545918_122546069 | 0.39 |
UBASH3B |
ubiquitin associated and SH3 domain containing B |
19610 |
0.22 |
chr6_41168130_41168571 | 0.39 |
TREML2 |
triggering receptor expressed on myeloid cells-like 2 |
582 |
0.65 |
chr11_46367528_46367907 | 0.39 |
DGKZ |
diacylglycerol kinase, zeta |
730 |
0.6 |
chr19_2281331_2281581 | 0.39 |
C19orf35 |
chromosome 19 open reading frame 35 |
719 |
0.44 |
chr11_104941043_104941194 | 0.39 |
CARD16 |
caspase recruitment domain family, member 16 |
25015 |
0.15 |
chr9_134148873_134149024 | 0.39 |
FAM78A |
family with sequence similarity 78, member A |
2986 |
0.24 |
chr1_93802327_93802478 | 0.39 |
ENSG00000223745 |
. |
547 |
0.77 |
chr1_36042987_36043882 | 0.38 |
RP4-728D4.2 |
|
104 |
0.95 |
chr3_112217855_112218341 | 0.38 |
BTLA |
B and T lymphocyte associated |
107 |
0.98 |
chr10_125799168_125799413 | 0.38 |
CHST15 |
carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15 |
6951 |
0.29 |
chr9_137288293_137289070 | 0.38 |
RXRA |
retinoid X receptor, alpha |
9747 |
0.23 |
chr4_74960008_74960159 | 0.38 |
CXCL2 |
chemokine (C-X-C motif) ligand 2 |
4927 |
0.18 |
chr21_43483571_43483940 | 0.38 |
UMODL1 |
uromodulin-like 1 |
687 |
0.71 |
chr19_13206703_13207270 | 0.38 |
LYL1 |
lymphoblastic leukemia derived sequence 1 |
6695 |
0.11 |
chr4_40207085_40207549 | 0.38 |
RHOH |
ras homolog family member H |
5353 |
0.24 |
chr1_207094320_207094619 | 0.38 |
FAIM3 |
Fas apoptotic inhibitory molecule 3 |
743 |
0.59 |
chr7_106507255_106507406 | 0.38 |
PIK3CG |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
1406 |
0.54 |
chr21_36419137_36419702 | 0.38 |
RUNX1 |
runt-related transcription factor 1 |
2043 |
0.49 |
chr2_198064152_198064348 | 0.38 |
ANKRD44 |
ankyrin repeat domain 44 |
1488 |
0.35 |
chr22_44578201_44578448 | 0.38 |
PARVG |
parvin, gamma |
583 |
0.83 |
chr17_27220072_27220391 | 0.38 |
RP11-20B24.7 |
|
744 |
0.4 |
chr2_430021_430194 | 0.38 |
FAM150B |
family with sequence similarity 150, member B |
141256 |
0.04 |
chr1_40524970_40525405 | 0.38 |
CAP1 |
CAP, adenylate cyclase-associated protein 1 (yeast) |
18633 |
0.16 |
chr5_171542788_171542949 | 0.38 |
ENSG00000266671 |
. |
34888 |
0.16 |
chr13_46752366_46752713 | 0.37 |
LCP1 |
lymphocyte cytosolic protein 1 (L-plastin) |
3920 |
0.19 |
chrX_118815979_118816490 | 0.37 |
SEPT6 |
septin 6 |
10558 |
0.17 |
chr2_106776864_106777181 | 0.37 |
UXS1 |
UDP-glucuronate decarboxylase 1 |
18 |
0.98 |
chr2_136873275_136873680 | 0.37 |
CXCR4 |
chemokine (C-X-C motif) receptor 4 |
336 |
0.93 |
chr8_21769513_21769765 | 0.37 |
DOK2 |
docking protein 2, 56kDa |
1535 |
0.4 |
chr13_100072035_100072186 | 0.37 |
ENSG00000266207 |
. |
33613 |
0.16 |
chrX_129225814_129226276 | 0.37 |
ELF4 |
E74-like factor 4 (ets domain transcription factor) |
18291 |
0.19 |
chr10_129861236_129861473 | 0.37 |
PTPRE |
protein tyrosine phosphatase, receptor type, E |
15520 |
0.26 |
chr17_17660862_17661247 | 0.37 |
RAI1-AS1 |
RAI1 antisense RNA 1 |
13081 |
0.13 |
chr1_111415148_111415389 | 0.37 |
CD53 |
CD53 molecule |
507 |
0.81 |
chr12_65063390_65063633 | 0.37 |
RP11-338E21.3 |
|
14712 |
0.13 |
chr13_33607800_33607951 | 0.37 |
ENSG00000221677 |
. |
7614 |
0.24 |
chr21_40138917_40139228 | 0.37 |
ETS2 |
v-ets avian erythroblastosis virus E26 oncogene homolog 2 |
38159 |
0.2 |
chr14_75714424_75714717 | 0.37 |
RP11-293M10.2 |
|
11544 |
0.15 |
chr7_37392669_37392863 | 0.37 |
ELMO1 |
engulfment and cell motility 1 |
506 |
0.77 |
chr13_91922419_91922570 | 0.37 |
ENSG00000215417 |
. |
80365 |
0.12 |
chr12_118797370_118797521 | 0.37 |
TAOK3 |
TAO kinase 3 |
36 |
0.98 |
chr16_3626426_3626694 | 0.37 |
NLRC3 |
NLR family, CARD domain containing 3 |
832 |
0.54 |
chr1_89664664_89664873 | 0.37 |
GBP4 |
guanylate binding protein 4 |
153 |
0.96 |
chr19_48761528_48762054 | 0.37 |
CARD8 |
caspase recruitment domain family, member 8 |
2588 |
0.17 |
chr16_29676714_29676865 | 0.37 |
QPRT |
quinolinate phosphoribosyltransferase |
2189 |
0.2 |
chrX_70323668_70324217 | 0.37 |
CXorf65 |
chromosome X open reading frame 65 |
2513 |
0.16 |
chr17_27912208_27912435 | 0.36 |
GIT1 |
G protein-coupled receptor kinase interacting ArfGAP 1 |
1431 |
0.21 |
chr2_120687234_120687484 | 0.36 |
PTPN4 |
protein tyrosine phosphatase, non-receptor type 4 (megakaryocyte) |
7 |
0.98 |
chr7_105318637_105318983 | 0.36 |
ATXN7L1 |
ataxin 7-like 1 |
799 |
0.74 |
chr6_128272436_128272587 | 0.36 |
THEMIS |
thymocyte selection associated |
32735 |
0.2 |
chr9_3398052_3398553 | 0.36 |
RFX3 |
regulatory factor X, 3 (influences HLA class II expression) |
2706 |
0.4 |
chr17_47765494_47765708 | 0.36 |
SPOP |
speckle-type POZ protein |
10005 |
0.14 |
chr9_139990412_139990681 | 0.36 |
ENSG00000199411 |
. |
1749 |
0.12 |
chr2_192540821_192541028 | 0.36 |
NABP1 |
nucleic acid binding protein 1 |
1938 |
0.47 |
chr11_118178183_118178334 | 0.36 |
CD3E |
CD3e molecule, epsilon (CD3-TCR complex) |
2644 |
0.19 |
chr9_126628860_126629011 | 0.36 |
DENND1A |
DENN/MADD domain containing 1A |
63451 |
0.12 |
chr9_127258219_127258370 | 0.36 |
NR5A1 |
nuclear receptor subfamily 5, group A, member 1 |
4971 |
0.23 |
chr17_19030873_19031152 | 0.36 |
GRAPL |
GRB2-related adaptor protein-like |
164 |
0.89 |
chr20_57237055_57237206 | 0.36 |
STX16 |
syntaxin 16 |
5446 |
0.18 |
chr4_148713676_148713874 | 0.36 |
ENSG00000264274 |
. |
10029 |
0.19 |
chr22_37881004_37881696 | 0.36 |
MFNG |
MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
683 |
0.62 |
chr3_140985922_140986285 | 0.36 |
ACPL2 |
acid phosphatase-like 2 |
4647 |
0.28 |
chr20_31127731_31127882 | 0.36 |
C20orf112 |
chromosome 20 open reading frame 112 |
3606 |
0.21 |
chr6_170580859_170581356 | 0.36 |
RP5-1086L22.1 |
|
9450 |
0.18 |
chr4_40198688_40199041 | 0.35 |
RHOH |
ras homolog family member H |
337 |
0.9 |
chr20_37503924_37504220 | 0.35 |
ENSG00000240474 |
. |
2659 |
0.29 |
chr19_7415020_7415240 | 0.35 |
CTB-133G6.1 |
|
1282 |
0.4 |
chr5_544016_544540 | 0.35 |
ENSG00000264233 |
. |
8281 |
0.14 |
chr12_54866933_54867431 | 0.35 |
GTSF1 |
gametocyte specific factor 1 |
201 |
0.92 |
chr7_36327271_36327770 | 0.35 |
EEPD1 |
endonuclease/exonuclease/phosphatase family domain containing 1 |
9233 |
0.18 |
chr17_38738771_38738954 | 0.35 |
CCR7 |
chemokine (C-C motif) receptor 7 |
17138 |
0.15 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.0 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.2 | 0.7 | GO:0046137 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.2 | 0.9 | GO:1901339 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.2 | 0.7 | GO:0010447 | response to acidic pH(GO:0010447) |
0.2 | 0.4 | GO:0002913 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) positive regulation of T cell anergy(GO:0002669) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) positive regulation of lymphocyte anergy(GO:0002913) |
0.2 | 0.6 | GO:0033622 | integrin activation(GO:0033622) |
0.2 | 0.5 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.2 | 0.5 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.1 | 0.6 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.1 | 0.4 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 0.6 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 1.3 | GO:0045061 | thymic T cell selection(GO:0045061) |
0.1 | 0.3 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.4 | GO:0051459 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.1 | 0.5 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.3 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.1 | 0.3 | GO:0015809 | arginine transport(GO:0015809) |
0.1 | 0.3 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.1 | 0.5 | GO:0007172 | signal complex assembly(GO:0007172) |
0.1 | 0.1 | GO:0002540 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.1 | 0.3 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.1 | 0.5 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.1 | 0.3 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.1 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.1 | 0.2 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.1 | 0.4 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
0.1 | 0.2 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.1 | 0.7 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.2 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
0.1 | 0.1 | GO:0043383 | negative T cell selection(GO:0043383) |
0.1 | 0.2 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.3 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.1 | 0.3 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.1 | 0.1 | GO:0090009 | primitive streak formation(GO:0090009) |
0.1 | 1.7 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.1 | 0.3 | GO:0010535 | regulation of activation of JAK2 kinase activity(GO:0010534) positive regulation of activation of JAK2 kinase activity(GO:0010535) |
0.1 | 0.3 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.1 | 0.1 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.1 | 0.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.2 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.9 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 0.1 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.1 | 0.2 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.1 | GO:0002666 | T cell tolerance induction(GO:0002517) regulation of T cell tolerance induction(GO:0002664) positive regulation of T cell tolerance induction(GO:0002666) |
0.1 | 0.2 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.3 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.4 | GO:0051642 | centrosome localization(GO:0051642) |
0.1 | 0.2 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.2 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 0.4 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.1 | 0.3 | GO:0032753 | positive regulation of interleukin-4 production(GO:0032753) |
0.1 | 0.1 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.1 | 0.3 | GO:0001562 | response to protozoan(GO:0001562) |
0.1 | 0.2 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.1 | 0.2 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.1 | 0.2 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.1 | 0.9 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 0.1 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.1 | 0.2 | GO:0001821 | histamine secretion(GO:0001821) |
0.1 | 0.2 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
0.1 | 0.1 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) auditory receptor cell fate determination(GO:0042668) inner ear receptor cell fate commitment(GO:0060120) |
0.1 | 0.2 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 0.6 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.1 | 0.2 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.0 | 2.4 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.0 | 0.2 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.0 | 0.1 | GO:0048541 | Peyer's patch development(GO:0048541) |
0.0 | 0.1 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.0 | 0.1 | GO:0070295 | renal water absorption(GO:0070295) |
0.0 | 0.3 | GO:0002467 | germinal center formation(GO:0002467) |
0.0 | 0.1 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.0 | 0.2 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.2 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.0 | 0.1 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.0 | 0.1 | GO:0046931 | pore complex assembly(GO:0046931) |
0.0 | 0.2 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.0 | 0.0 | GO:0035304 | regulation of protein dephosphorylation(GO:0035304) |
0.0 | 0.1 | GO:0032928 | regulation of superoxide anion generation(GO:0032928) |
0.0 | 0.1 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.0 | 0.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.0 | 0.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.0 | 0.2 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.0 | 0.1 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.0 | 0.0 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.0 | 0.1 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) |
0.0 | 0.2 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.0 | 0.1 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.0 | 0.1 | GO:0045359 | interferon-beta biosynthetic process(GO:0045350) regulation of interferon-beta biosynthetic process(GO:0045357) positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.0 | 0.1 | GO:0002885 | positive regulation of hypersensitivity(GO:0002885) |
0.0 | 0.0 | GO:0090322 | regulation of superoxide metabolic process(GO:0090322) |
0.0 | 0.1 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.0 | 0.3 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.0 | 0.3 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.4 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.0 | 0.2 | GO:0032747 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
0.0 | 0.1 | GO:0015816 | glycine transport(GO:0015816) |
0.0 | 0.2 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.0 | 0.1 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.0 | 0.1 | GO:0051132 | NK T cell activation(GO:0051132) |
0.0 | 0.1 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.0 | 0.3 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.2 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.0 | 0.6 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.0 | 0.1 | GO:0032506 | cytokinetic process(GO:0032506) |
0.0 | 0.1 | GO:1900120 | regulation of receptor binding(GO:1900120) negative regulation of receptor binding(GO:1900121) |
0.0 | 0.1 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.0 | 0.2 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.0 | 0.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.0 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.0 | 0.5 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.0 | 0.1 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.0 | 0.0 | GO:0060744 | thelarche(GO:0042695) development of secondary female sexual characteristics(GO:0046543) mammary gland branching involved in thelarche(GO:0060744) |
0.0 | 0.3 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.0 | 0.1 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.0 | 0.0 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.1 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.0 | 0.1 | GO:0034695 | response to prostaglandin E(GO:0034695) |
0.0 | 0.1 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.0 | 0.2 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.0 | 0.0 | GO:0010536 | regulation of activation of Janus kinase activity(GO:0010533) positive regulation of activation of Janus kinase activity(GO:0010536) |
0.0 | 0.1 | GO:0006922 | obsolete cleavage of lamin involved in execution phase of apoptosis(GO:0006922) |
0.0 | 0.1 | GO:0045885 | obsolete positive regulation of survival gene product expression(GO:0045885) |
0.0 | 0.1 | GO:0034626 | fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.0 | 0.5 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.1 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.0 | 0.1 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
0.0 | 0.1 | GO:0003032 | detection of oxygen(GO:0003032) |
0.0 | 0.1 | GO:0009405 | pathogenesis(GO:0009405) |
0.0 | 0.1 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.0 | 0.1 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.0 | 0.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.0 | 0.0 | GO:0048143 | astrocyte activation(GO:0048143) |
0.0 | 0.1 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.0 | 0.1 | GO:0007412 | axon target recognition(GO:0007412) |
0.0 | 0.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.1 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.0 | 0.0 | GO:0048478 | replication fork protection(GO:0048478) |
0.0 | 0.1 | GO:0090382 | phagolysosome assembly(GO:0001845) phagosome maturation(GO:0090382) |
0.0 | 0.2 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.0 | 0.1 | GO:0016115 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.0 | 0.1 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.0 | 0.2 | GO:0021554 | optic nerve development(GO:0021554) |
0.0 | 0.4 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.0 | 0.1 | GO:0007042 | lysosomal lumen acidification(GO:0007042) regulation of lysosomal lumen pH(GO:0035751) |
0.0 | 0.1 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.0 | 0.1 | GO:0070293 | renal absorption(GO:0070293) |
0.0 | 0.2 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.0 | 0.5 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.0 | 0.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.2 | GO:0045749 | obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
0.0 | 0.1 | GO:0043276 | anoikis(GO:0043276) |
0.0 | 0.0 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.0 | 0.1 | GO:0042992 | negative regulation of transcription factor import into nucleus(GO:0042992) |
0.0 | 0.2 | GO:0097191 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.0 | 0.1 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) |
0.0 | 0.1 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.0 | 0.3 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.1 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.0 | 0.1 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.0 | 0.1 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
0.0 | 0.1 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.0 | 0.0 | GO:0032232 | negative regulation of actin filament bundle assembly(GO:0032232) |
0.0 | 0.1 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.0 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.1 | GO:0014742 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.0 | 0.2 | GO:0048535 | lymph node development(GO:0048535) |
0.0 | 0.1 | GO:1901797 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.0 | 0.3 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.0 | 0.7 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.0 | 0.1 | GO:0018101 | protein citrullination(GO:0018101) |
0.0 | 1.4 | GO:0050851 | antigen receptor-mediated signaling pathway(GO:0050851) |
0.0 | 0.6 | GO:0046847 | filopodium assembly(GO:0046847) |
0.0 | 0.2 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.0 | 0.1 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.1 | GO:0051708 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) regulation by virus of viral protein levels in host cell(GO:0046719) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.0 | 0.7 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.0 | 0.1 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 0.1 | GO:0061028 | establishment of endothelial barrier(GO:0061028) |
0.0 | 0.2 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.0 | 0.1 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.0 | 0.1 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.0 | 1.2 | GO:0060337 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.0 | 0.3 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.0 | 0.1 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.0 | 0.4 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.0 | 0.0 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.0 | 0.3 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.0 | 0.9 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.0 | 0.1 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 0.0 | GO:0002830 | positive regulation of type 2 immune response(GO:0002830) |
0.0 | 0.0 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.0 | 0.2 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.0 | 0.0 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.0 | 0.0 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
0.0 | 0.2 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.1 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.0 | 0.0 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.0 | 0.2 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.0 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.0 | 0.2 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.0 | GO:0048261 | negative regulation of receptor-mediated endocytosis(GO:0048261) |
0.0 | 0.2 | GO:0072599 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.0 | 0.2 | GO:1903038 | negative regulation of T cell activation(GO:0050868) negative regulation of leukocyte cell-cell adhesion(GO:1903038) |
0.0 | 0.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.0 | 0.1 | GO:0019605 | butyrate metabolic process(GO:0019605) |
0.0 | 0.1 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.0 | 0.0 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
0.0 | 0.0 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.0 | 0.0 | GO:0010560 | positive regulation of glycoprotein biosynthetic process(GO:0010560) positive regulation of glycoprotein metabolic process(GO:1903020) |
0.0 | 0.1 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.0 | 0.0 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.0 | 0.1 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) positive regulation of meiotic cell cycle(GO:0051446) |
0.0 | 0.2 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.1 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.0 | 0.0 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.0 | 0.0 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.0 | 0.2 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.0 | 0.0 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.0 | 0.3 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.0 | 0.0 | GO:0045079 | negative regulation of chemokine production(GO:0032682) negative regulation of chemokine biosynthetic process(GO:0045079) |
0.0 | 0.2 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.0 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.2 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.0 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.0 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.3 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.0 | 0.1 | GO:0010586 | miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) |
0.0 | 0.2 | GO:0006595 | polyamine metabolic process(GO:0006595) |
0.0 | 0.1 | GO:0009103 | lipopolysaccharide biosynthetic process(GO:0009103) |
0.0 | 0.2 | GO:0051319 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.0 | 0.0 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.0 | 0.1 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.0 | 0.0 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.0 | 0.0 | GO:0002532 | production of molecular mediator involved in inflammatory response(GO:0002532) |
0.0 | 0.1 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.0 | 0.1 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.0 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 0.0 | GO:0032691 | negative regulation of interleukin-1 beta production(GO:0032691) negative regulation of interleukin-1 production(GO:0032692) |
0.0 | 0.0 | GO:0001783 | B cell apoptotic process(GO:0001783) |
0.0 | 0.1 | GO:0048488 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.0 | 0.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 0.1 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.0 | 0.1 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.0 | 0.1 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.1 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.0 | 0.1 | GO:0048242 | epinephrine transport(GO:0048241) epinephrine secretion(GO:0048242) |
0.0 | 0.3 | GO:0045730 | respiratory burst(GO:0045730) |
0.0 | 0.1 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.0 | 0.0 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.0 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.0 | 0.1 | GO:0050718 | positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.0 | 0.0 | GO:0070602 | centromeric sister chromatid cohesion(GO:0070601) regulation of centromeric sister chromatid cohesion(GO:0070602) |
0.0 | 0.0 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.0 | 0.0 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.0 | 0.0 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.0 | 0.0 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.0 | 0.0 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.0 | 0.1 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.1 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.0 | 0.1 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.0 | 0.4 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.0 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.0 | 0.3 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.0 | 0.0 | GO:0021780 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) glial cell fate specification(GO:0021780) |
0.0 | 0.0 | GO:0045010 | actin nucleation(GO:0045010) |
0.0 | 0.1 | GO:0097502 | protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) mannosylation(GO:0097502) |
0.0 | 0.1 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
0.0 | 0.0 | GO:0003161 | cardiac conduction system development(GO:0003161) |
0.0 | 0.1 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.0 | 0.2 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.1 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 0.1 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.0 | 0.2 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
0.0 | 0.1 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.3 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.0 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.0 | 0.3 | GO:0051017 | actin filament bundle assembly(GO:0051017) actin filament bundle organization(GO:0061572) |
0.0 | 0.1 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.0 | 0.1 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.0 | 0.0 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.0 | 0.0 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.0 | 0.0 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.0 | 0.0 | GO:0019348 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
0.0 | 0.0 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.0 | 0.0 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.0 | 0.1 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.0 | 0.2 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.0 | 0.0 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.0 | 0.0 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.0 | 0.0 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.0 | 0.1 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.0 | 0.1 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 0.1 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.0 | 0.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.1 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.0 | 0.1 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.1 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.0 | 0.2 | GO:0030316 | osteoclast differentiation(GO:0030316) |
0.0 | 0.1 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.0 | 0.1 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.0 | 0.0 | GO:0010903 | cytokine secretion involved in immune response(GO:0002374) regulation of cytokine secretion involved in immune response(GO:0002739) negative regulation of cytokine secretion involved in immune response(GO:0002740) negative regulation of very-low-density lipoprotein particle remodeling(GO:0010903) |
0.0 | 0.7 | GO:0042177 | negative regulation of protein catabolic process(GO:0042177) |
0.0 | 0.1 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.0 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.0 | 0.0 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.0 | 0.1 | GO:0042119 | neutrophil activation(GO:0042119) |
0.0 | 0.0 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.1 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.0 | 0.0 | GO:0060088 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.0 | 0.5 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.0 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.0 | 0.0 | GO:0006562 | proline catabolic process(GO:0006562) |
0.0 | 0.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.1 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.0 | 0.0 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.0 | 2.5 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.0 | 0.0 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.0 | 0.2 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.0 | 0.0 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.0 | 0.0 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
0.0 | 0.0 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.0 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.0 | 0.0 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.0 | 0.1 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.0 | 0.1 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.0 | 0.1 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.0 | 0.1 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.2 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.0 | 0.0 | GO:0046015 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
0.0 | 0.0 | GO:0010915 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.0 | 0.0 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.0 | 0.0 | GO:0070391 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.0 | 0.0 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.0 | 0.0 | GO:0046638 | positive regulation of alpha-beta T cell differentiation(GO:0046638) |
0.0 | 0.1 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.1 | GO:0009129 | pyrimidine nucleoside monophosphate metabolic process(GO:0009129) |
0.0 | 0.1 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.0 | 0.0 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.0 | 0.0 | GO:0045822 | negative regulation of heart contraction(GO:0045822) |
0.0 | 0.0 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.0 | 0.0 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.0 | 0.0 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.0 | 0.1 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.0 | 0.0 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.0 | 0.3 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.0 | 0.0 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.2 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.2 | GO:0043631 | RNA polyadenylation(GO:0043631) |
0.0 | 0.0 | GO:0048525 | negative regulation of viral process(GO:0048525) negative regulation of viral life cycle(GO:1903901) |
0.0 | 0.0 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.0 | 0.1 | GO:0009268 | response to pH(GO:0009268) |
0.0 | 0.1 | GO:0001706 | endoderm formation(GO:0001706) |
0.0 | 0.0 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.0 | 0.0 | GO:0001961 | positive regulation of cytokine-mediated signaling pathway(GO:0001961) |
0.0 | 0.0 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.0 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.0 | 0.0 | GO:0075136 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.0 | 0.0 | GO:0032645 | granulocyte macrophage colony-stimulating factor production(GO:0032604) regulation of granulocyte macrophage colony-stimulating factor production(GO:0032645) |
0.0 | 0.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.0 | 0.0 | GO:0061140 | lung saccule development(GO:0060430) Type II pneumocyte differentiation(GO:0060510) lung secretory cell differentiation(GO:0061140) |
0.0 | 0.1 | GO:0070972 | protein localization to endoplasmic reticulum(GO:0070972) |
0.0 | 0.0 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.0 | 0.0 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.0 | 0.0 | GO:0061082 | myeloid leukocyte cytokine production(GO:0061082) |
0.0 | 0.2 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 0.1 | GO:0032456 | endocytic recycling(GO:0032456) |
0.0 | 0.0 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.0 | 0.1 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.0 | 0.2 | GO:0034341 | response to interferon-gamma(GO:0034341) |
0.0 | 0.0 | GO:0033158 | regulation of protein import into nucleus, translocation(GO:0033158) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.8 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.2 | 1.0 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.1 | 0.5 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.5 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.1 | 0.5 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 0.2 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.5 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.4 | GO:0032279 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.0 | 0.6 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 0.1 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.0 | 0.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.2 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 0.2 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.5 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.2 | GO:0042827 | platelet dense granule(GO:0042827) |
0.0 | 0.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.4 | GO:0042627 | chylomicron(GO:0042627) |
0.0 | 0.2 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.0 | 1.6 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.2 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.3 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.2 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.2 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.1 | GO:0032009 | early phagosome(GO:0032009) |
0.0 | 0.2 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.0 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 0.1 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.1 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.0 | 0.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.1 | GO:0042584 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.0 | 0.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.0 | 0.1 | GO:0070062 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.0 | 0.1 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.3 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.1 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.1 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.0 | 0.1 | GO:0032059 | bleb(GO:0032059) |
0.0 | 0.2 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.2 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.0 | 0.6 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 2.6 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.7 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.0 | 0.3 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.1 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.0 | 1.5 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.0 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 0.4 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.2 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 0.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.0 | 0.2 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.0 | 0.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.4 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 0.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.0 | 0.1 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 0.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.0 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.0 | 0.1 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.0 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.0 | 0.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.1 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.0 | 0.1 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.0 | 0.2 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 0.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.0 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.0 | 0.6 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.1 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.0 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.0 | 0.2 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.0 | 0.1 | GO:0097526 | U4/U6 x U5 tri-snRNP complex(GO:0046540) spliceosomal tri-snRNP complex(GO:0097526) |
0.0 | 0.2 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.0 | 0.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.0 | 0.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.3 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.1 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.6 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 0.0 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.1 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.0 | 0.1 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.0 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.1 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 0.4 | GO:0005903 | brush border(GO:0005903) |
0.0 | 0.5 | GO:0031901 | early endosome membrane(GO:0031901) |
0.0 | 0.1 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.2 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 0.0 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 0.0 | GO:0030891 | VCB complex(GO:0030891) |
0.0 | 0.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.0 | 0.0 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.1 | GO:0030130 | trans-Golgi network transport vesicle membrane(GO:0012510) clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.0 | 0.1 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.0 | 0.1 | GO:0017119 | Golgi transport complex(GO:0017119) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.6 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.2 | 0.6 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.1 | 0.7 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.1 | 1.1 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.1 | 0.7 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 0.5 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.3 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.3 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.6 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.2 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 0.1 | GO:0019958 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) |
0.1 | 0.4 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 1.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 0.2 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.1 | 0.2 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.3 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.1 | 0.3 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.8 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.1 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 0.5 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.1 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
0.1 | 0.2 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.1 | 0.2 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.1 | 0.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.2 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.1 | 0.2 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 0.3 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 0.2 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.1 | 0.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.4 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.0 | 0.8 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.0 | 0.3 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.0 | 0.0 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 0.3 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.0 | 0.1 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.0 | 1.8 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.8 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.0 | 0.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.3 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.2 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.1 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.0 | 0.5 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.0 | 0.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.2 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 0.1 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.0 | 0.2 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.0 | 0.2 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.2 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.2 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.0 | 0.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 1.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.1 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.3 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.0 | 0.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 0.2 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.0 | 0.1 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.0 | 0.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.0 | 0.5 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.0 | 0.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 0.4 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.0 | 0.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 0.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.0 | 0.2 | GO:0051766 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.0 | 0.5 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.0 | 0.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.2 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.1 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.0 | 0.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.0 | 0.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.7 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
0.0 | 0.0 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.0 | 0.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.0 | 0.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.0 | 0.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.0 | 0.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 0.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.2 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.1 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.0 | 0.7 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.2 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.1 | GO:0004476 | mannose-6-phosphate isomerase activity(GO:0004476) |
0.0 | 0.1 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.0 | 0.2 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.0 | 0.1 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.1 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.0 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.1 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.6 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.1 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.0 | 0.1 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.0 | 0.1 | GO:0004437 | obsolete inositol or phosphatidylinositol phosphatase activity(GO:0004437) |
0.0 | 0.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.0 | 0.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.1 | GO:0003896 | DNA primase activity(GO:0003896) |
0.0 | 0.2 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.0 | 0.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.0 | 0.1 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.0 | 0.2 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 0.2 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.3 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 0.0 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.0 | 0.1 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.0 | 0.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.9 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.0 | 0.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 0.1 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.0 | 0.1 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.0 | 0.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.1 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.0 | 0.1 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.0 | 0.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.0 | 0.3 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.0 | 0.2 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.0 | 0.2 | GO:0019864 | IgG binding(GO:0019864) |
0.0 | 0.3 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.1 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.1 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.0 | 0.0 | GO:0031014 | troponin T binding(GO:0031014) |
0.0 | 0.1 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.5 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 0.1 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.0 | 0.1 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.0 | 0.1 | GO:0004396 | hexokinase activity(GO:0004396) |
0.0 | 0.1 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.2 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.0 | 0.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.0 | 0.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.1 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.0 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.0 | 0.2 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.0 | 0.3 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 0.1 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.1 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.0 | 0.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 1.1 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.5 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.0 | 0.0 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.0 | 0.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.1 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.0 | 0.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.1 | GO:0097493 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.6 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 0.1 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.0 | 0.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.4 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.0 | 0.1 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.0 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.0 | 0.2 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.0 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.0 | 0.0 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.0 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.0 | GO:0045569 | TRAIL binding(GO:0045569) |
0.0 | 0.4 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.2 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.0 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.0 | 0.1 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.0 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.0 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.2 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.0 | 0.0 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.0 | 0.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.1 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.0 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.0 | 0.1 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.0 | GO:0043398 | HLH domain binding(GO:0043398) |
0.0 | 0.0 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.0 | 0.0 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) |
0.0 | 0.3 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.0 | 0.2 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.0 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.1 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.0 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.0 | 0.0 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.0 | 0.1 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.0 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.0 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.0 | 0.1 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.2 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 0.0 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.2 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 0.0 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.0 | 0.1 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.0 | 0.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.1 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.0 | 0.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.4 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.3 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.0 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.0 | 0.0 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 0.2 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.0 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.0 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 0.0 | GO:0099528 | dopamine neurotransmitter receptor activity(GO:0004952) G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.0 | 0.0 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.1 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.0 | 0.2 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 0.0 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.0 | 0.0 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.0 | 0.0 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.1 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.0 | 0.1 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.0 | 0.1 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.0 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.1 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.0 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.0 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.0 | 0.0 | GO:0031708 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.0 | 0.0 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.0 | 0.1 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 0.0 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.1 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.0 | 0.0 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.0 | 0.3 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.6 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.2 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.0 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.0 | 0.1 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.0 | 0.3 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 0.1 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.0 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.0 | 0.0 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.2 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.0 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.2 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.0 | 0.0 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.0 | 0.0 | GO:0030354 | melanin-concentrating hormone activity(GO:0030354) |
0.0 | 0.0 | GO:0004803 | transposase activity(GO:0004803) |
0.0 | 0.0 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.0 | 0.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.1 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.0 | 0.0 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.0 | 0.0 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.1 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.0 | 0.1 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.1 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.0 | 0.1 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.3 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.0 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 7.1 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 0.8 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 0.8 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 0.5 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 1.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 0.8 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 1.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 1.2 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 1.0 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.8 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 1.1 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.6 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 1.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.6 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.3 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 0.0 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.4 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.2 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.8 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.0 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.4 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.1 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.8 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.5 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.2 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.1 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.0 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.8 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.8 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.6 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.3 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.2 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.0 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.6 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 0.3 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 1.9 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 1.7 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 0.9 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 1.7 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 0.7 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 0.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.8 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 1.0 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.6 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 0.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.3 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.5 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 1.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.5 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 1.4 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.4 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.8 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.0 | 0.6 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.0 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 1.1 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.5 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.3 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.0 | 0.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.7 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 0.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.1 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.3 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 1.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 1.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.3 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 0.2 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.2 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.0 | 0.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.5 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.5 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 0.4 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.0 | 0.3 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.3 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.0 | 0.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.0 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
0.0 | 0.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.1 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.3 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.0 | 0.3 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.4 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.4 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.2 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.5 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.1 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.0 | 0.1 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.0 | 0.1 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.2 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.0 | 0.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.0 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.4 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.0 | 0.1 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.0 | 0.4 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.0 | 0.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.3 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.7 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 1.0 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.2 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.0 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.1 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.1 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.0 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 0.4 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.3 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.0 | 0.4 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.0 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.0 | 0.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.0 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
0.0 | 0.1 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 0.0 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.0 | 0.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.2 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.1 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.0 | 0.1 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.1 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |